|NIH Human Embryonic Stem Cell Registry|
|Research Using This Line is Eligible for NIH Funding|
Detailed information for selected cell line:
|Cell Line:||UCLA 7; disease-specific mutation/abnormal karyotype|
|NIH Registration Number:||0143|
|NIH Approval Number:||NIHhESC-12-0143|
|Available for Distribution:||Other - possibly in future: contact firstname.lastname@example.org|
hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.
|NIH Restrictions:||(No Additional Restrictions)|
UCLA 7 (47, XX+13) was karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.
|Submitting Organization:||University of California, Los Angeles|
|Provider Name:||Steven Peckman|
(Emails that are offensive or unrelated to stem cells will be deleted.)